Related Experiment Video
Updated: Jun 3, 2025
09:55
All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
2.9K
Nucleus Accumbens Associated Protein 1 in Cancers-The Real Value
Marlena Janiczek-Polewska1,2, Tomasz Kolenda3, Paulina Poter4
1Department of Clinical Oncology, Greater Poland Cancer Center, 61-866 Poznan, Poland.
International Journal of Molecular Sciences
|January 8, 2025
Summary
Nucleus accumbens associated protein 1 (NACC1) is involved in many cancers, affecting pathogenesis and immune response. While not a diagnostic biomarker, NACC1 shows potential as a therapeutic target to improve cancer treatment effectiveness.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Malignant tumors are a leading global cause of death, presenting significant diagnostic and therapeutic challenges.
- Understanding the diverse etiopathogenesis of cancer is crucial for developing effective treatments.
- Nucleus accumbens associated protein 1 (NACC1), a transcriptional coregulator, is implicated in promoting tumorigenesis.
Purpose of the Study:
- To analyze NACC1 expression across various cancers using The Cancer Genome Atlas (TCGA) data.
- To investigate the correlation between NACC1 expression and clinicopathological parameters.
- To evaluate NACC1's potential as a diagnostic biomarker and therapeutic target in cancer.
Main Methods:
- Utilized The Cancer Genome Atlas (TCGA) data accessed via the University of Alabama at Birmingham Cancer (UALCAN) database for NACC1 expression analysis.
- Interconnected NACC1 expression data with clinicopathological parameters.
- Performed statistical analyses using GraphPad Prism and Statistica.
Main Results:
- NACC1 was found to be expressed in nearly all analyzed cancer types.
- NACC1 expression levels correlated with various clinicopathological parameters.
- The study indicates NACC1's involvement in cancer pathogenesis, invasion, and immune response.
Conclusions:
- NACC1 is broadly expressed in malignancies and plays a role in cancer development and progression.
- NACC1 is not a suitable diagnostic biomarker due to lack of specificity and expression discrepancies.
- Targeting NACC1 therapeutically may enhance the efficacy of cancer treatments.
Related Concept Videos
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:55The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
01:35Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K